Avid Bioservices Inc (CDMO)
12.11
+0.18
(+1.51%)
USD |
NASDAQ |
Nov 15, 11:43
Avid Bioservices Free Cash Flow (Quarterly): -4.991M for July 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | -4.991M |
| April 30, 2024 | -4.436M |
| January 31, 2024 | -0.801M |
| October 31, 2023 | -1.224M |
| July 31, 2023 | -14.39M |
| April 30, 2023 | -22.08M |
| January 31, 2023 | -18.24M |
| October 31, 2022 | -38.24M |
| July 31, 2022 | -11.96M |
| April 30, 2022 | -23.95M |
| January 31, 2022 | -14.83M |
| October 31, 2021 | 2.978M |
| July 31, 2021 | -11.14M |
| April 30, 2021 | 13.71M |
| January 31, 2021 | 2.452M |
| October 31, 2020 | 7.915M |
| July 31, 2020 | -2.762M |
| April 30, 2020 | 2.26M |
| January 31, 2020 | -2.676M |
| October 31, 2019 | 4.937M |
| July 31, 2019 | -2.506M |
| April 30, 2019 | 5.394M |
| January 31, 2019 | -3.884M |
| October 31, 2018 | -6.967M |
| July 31, 2018 | -7.64M |
| Date | Value |
|---|---|
| April 30, 2018 | 0.46M |
| January 31, 2018 | -8.968M |
| October 31, 2017 | -8.664M |
| July 31, 2017 | -12.61M |
| April 30, 2017 | -12.54M |
| January 31, 2017 | -12.41M |
| October 31, 2016 | 0.344M |
| July 31, 2016 | -18.20M |
| April 30, 2016 | -6.586M |
| January 31, 2016 | -10.77M |
| October 31, 2015 | -12.78M |
| July 31, 2015 | -18.33M |
| April 30, 2015 | -6.65M |
| January 31, 2015 | -11.69M |
| October 31, 2014 | -12.73M |
| July 31, 2014 | -13.99M |
| April 30, 2014 | -6.721M |
| January 31, 2014 | -8.625M |
| October 31, 2013 | -5.512M |
| July 31, 2013 | -8.151M |
| April 30, 2013 | -4.883M |
| January 31, 2013 | -6.929M |
| October 31, 2012 | -9.676M |
| July 31, 2012 | -0.291M |
| April 30, 2012 | -9.187M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-38.24M
Minimum
Oct 2022
13.71M
Maximum
Apr 2021
-7.495M
Average
-4.436M
Median
Apr 2024
Free Cash Flow (Quarterly) Benchmarks
| MEI Pharma Inc | -18.00M |
| Altimmune Inc | -18.11M |
| NovaBay Pharmaceuticals Inc | -2.063M |
| Palatin Technologies Inc | -6.477M |
| iBio Inc | -4.854M |